Invasive Breast Lobular Carcinoma — Trials

Invasive Breast Lobular Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

21 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 8
Recruiting: 5
Ph III recruiting: 0
Growth YoY: —
Industry share: 25%
Top sponsor: Blue Earth Diagnostics
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–9 of 9 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07702292	[68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications	recruiting	Phase 2	71	Blue Earth DiagnosticsINDUSTRY	2	Sep 15, 2026	clinicaltrials
NCT05269381	Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors(PNeoVCA)	recruiting	Phase 1 / Phase 2	138	Mayo ClinicOTHER	1	Aug 20, 2026	clinicaltrials